Vyepti (eptinezumab) decreases the monthly frequency of both episodic and chronic migraine and can reduce symptoms within one day for more immediate relief.

Living With Chronic Pain

March 05, 2020

FDA Approves First IV Therapy to Prevent Migraine Attacks

Vyepti (eptinezumab) decreases the monthly frequency of both episodic and chronic migraine and can reduce symptoms within one day for more immediate relief.

Soon, Arthritis Pain Gel Won't Require an RX

Learn about the medication that's switching from prescription to OTC.

The Best Endo Influencers to Follow

Learn how these health advocates are changing the game for endometriosis.

Eat Right to Ease Fibromyalgia Pain

When you have fibromyalgia, what's on your plate can make a big difference in how you feel and function.

Taking This May Save Your Knees

There may be a new way to protect knees from wear and tear arthritis.

Sign Up for More Newsletters

Healthy Living

Heart Health

Don't see something you're interested in? Browse our other newsletters.

Thanks for joining our mailing list. You registered with newsletter@newslettercollector.com for Everyday Health: Living With Chronic Pain.

Remove me from this list | Add me to this list | Manage my email settings | Customer Service

Copyright © 2020 Everyday Health, Inc. All rights reserved.

345 Hudson Street, 16th Floor, New York, NY 10014

Subject to our terms of service and privacy policy